New class of agents for treatment of hypertension: Focus on direct renin inhibition
Roberto Fogari, Annalisa ZoppiDepartment of Internal Medicine and Therapeutics, University of Pavia, ItalyAbstract: Aliskiren, the first orally active direct renin inhibitor, is an effective antihypertensive drug with distinctive characteristics, including good blockade of the renin-angiotensin syst...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-10-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | http://www.dovepress.com/new-class-of-agents-for-treatment-of-hypertension-focus-on-direct-reni-a5432 |